Skip to content
healthcare.dev

Adalimumab-bwwd

NDC 83457-187, adalimumab-bwwd, solution, from Cordavis Limited.

Product NDC
83457-187
Status
Listed
Labeler
Cordavis Limited
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761059
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83457-187 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADALIMUMAB40 mg/.4mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Package NDCNDC-11Package
83457-187-01834570187012 SYRINGE in 1 CARTON (83457-187-01) / .4 mL in 1 SYRINGE (83457-187-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c24655e5-796e-4127-b716-92f08d649c83

Use it

Look up 83457-187 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83457-187 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83457-187. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.